| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/01/1999 | EP0755517B1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 12/01/1999 | EP0667782B1 Reconstituted platelet membrane vesicles |
| 12/01/1999 | CN1237209A Herpesvirus saimiri as viral vector |
| 12/01/1999 | CN1236643A Medicine for curing impotence |
| 12/01/1999 | CN1236639A Chinese patent medicine for treating chronic gastritis and peptic ulcer |
| 12/01/1999 | CN1236638A Medical wine for treating rheumatism |
| 12/01/1999 | CN1236637A Medicine for curing children's diarrhae |
| 12/01/1999 | CN1236635A Liniment for preventing and treating hyperosteogeny and rheumotism |
| 12/01/1999 | CN1236622A Medicine for treating intractable ulcer and its preparing process |
| 12/01/1999 | CN1046855C Traditional chinese medicine for curing gastric disease |
| 11/30/1999 | US5994404 Nervonic acid compositions |
| 11/30/1999 | US5994322 Compositions for preventing dementia |
| 11/30/1999 | US5994301 Corpuscles of stannius protein, stanniocalcin |
| 11/30/1999 | US5994128 Primary cells containing a nucleic acid molecule from the adenovirus early genes, eia and eib; an encapsidating signal sequence and an inverted terminal repeat with no overlapping sequences with the target cells; autoimmune disease therapy |
| 11/30/1999 | US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 11/30/1999 | US5994126 Obtaining dendritic cell precursors from tissue, culturing on a substrate in medium containing colony stimulating factor to obtain proliferating nonadherent mature cells; therapy for juvenile diabetes, autoimmune diseases, multiple sclerosis |
| 11/30/1999 | US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics |
| 11/30/1999 | US5994106 Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus |
| 11/30/1999 | US5994096 Regulator |
| 11/30/1999 | US5994083 Collect serum samples from infected pateints with antibodies and a healthy individual, identify antibodies which bind antigens specific to the disease from phage library; select phages that display antigen recognized by antibody; vaccines |
| 11/30/1999 | US5993821 Antigens and vaccines containing said vlps that may be effective in treatment of infections caused by such viruses. |
| 11/30/1999 | US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies |
| 11/30/1999 | US5993804 Pharmaceutically acceptable fixed-dried human blood platelets |
| 11/30/1999 | US5993799 Methods of using genetically engineered cells that produce insulin in response to glucose |
| 11/30/1999 | US5993783 Aerosols |
| 11/30/1999 | CA2154111C Apparatus for inhibiting glycolysis in blood samples |
| 11/30/1999 | CA2079077C Tissue glue prepared by using cryoprecipitate |
| 11/30/1999 | CA1340833C Activated killer monocytes: tumoricidal activity and method of monitoring same |
| 11/25/1999 | WO1999060145A1 Mutant herpes simplex viruses and uses thereof |
| 11/25/1999 | WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
| 11/25/1999 | WO1999060105A1 Flat sheet cell encapsulation device |
| 11/25/1999 | WO1999060021A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system |
| 11/25/1999 | WO1999060008A1 Cytosine deaminase gene |
| 11/25/1999 | WO1999059694A1 Method and apparatus for magnetically separating selected particles, particularly biological cells |
| 11/25/1999 | WO1999059645A1 Methods and apparatus for inactivating contaminants in biological fluid |
| 11/25/1999 | WO1999059617A2 Immunoregulator |
| 11/25/1999 | WO1999059610A2 Use of lipopeptides or lipoproteins for wound treatment |
| 11/25/1999 | WO1999059604A1 Adenovirus-chemotherapeutic combination for treating cancer |
| 11/25/1999 | WO1999059506A1 Corporal tissue penile reconstruction |
| 11/25/1999 | WO1999049014A9 Localization and propagation of neural and neuronal progenitor cells |
| 11/25/1999 | WO1999048507A3 Steroidal saponins for treating alzheimer's disease |
| 11/25/1999 | WO1999043787A3 A living chimeric skin replacement |
| 11/25/1999 | WO1999040924A3 Treatment of neurodegeneration |
| 11/25/1999 | WO1999040180A9 Expanded and genetically modified populations of human hematopoietic stem cells |
| 11/25/1999 | WO1999035495A3 Identification of substances that modify cellular secretory function |
| 11/25/1999 | DE19822820A1 Wound healing composition comprising lipopeptide or lipoprotein that stimulates leukocyte infiltration |
| 11/25/1999 | CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
| 11/25/1999 | CA2328596A1 Cytosine deaminase gene |
| 11/25/1999 | CA2328594A1 Mutant herpes simplex viruses and uses thereof |
| 11/25/1999 | CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation |
| 11/25/1999 | CA2326323A1 Adenovirus-chemotherapeutic combination for treating cancer |
| 11/24/1999 | EP0958828A1 Artichoke containing preparation especially for use as medicaments or nutritional supplement |
| 11/24/1999 | EP0958826A1 Immunotherapeutic agent for cancer containing nucleoidal component of bacterium as active ingredient |
| 11/24/1999 | EP0958371A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 11/24/1999 | EP0958361A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 11/24/1999 | EP0957944A2 Bone matrix, the utilization thereof, therapeutic preparation and kit |
| 11/24/1999 | EP0957941A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
| 11/24/1999 | EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 11/24/1999 | EP0550703B1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs |
| 11/24/1999 | EP0516839B1 Systems and methods for simultaneously removing free and entrained contaminants in fluids like blood using photoactive therapy and cellular separation techniques |
| 11/24/1999 | CN1236390A Angiogenic factor and use thereof of treating cardiovascular disease |
| 11/24/1999 | CN1235845A Health care liquid and its preparing method |
| 11/24/1999 | CN1235837A Psoriasis paster |
| 11/24/1999 | CN1235834A Pearl water for heatlh care |
| 11/24/1999 | CN1235831A Medicinal composition containing globoside and its use |
| 11/24/1999 | CN1046691C Method for colouring piece of rock by laser rays |
| 11/23/1999 | US5990388 Transgenic plant expressing a cloned dna encoding a vaccinia virus e3l protein at a level to complex and sequester double-stranded rna-like structure of virus/viroid; biological pest control; viricides |
| 11/23/1999 | US5990381 Biomedical materials |
| 11/23/1999 | US5990100 Composition and method for treatment of psoriasis |
| 11/23/1999 | US5990091 First nucleic acid molecule to be expressed, and a second nucleic acid molecule encoding a transcription factor and translation factor, where there is co-temporal expression so expression of the second enhances expression of the first |
| 11/23/1999 | US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus |
| 11/23/1999 | US5989594 Ratite extracts as therapeutic agents |
| 11/23/1999 | US5989592 Inhibition of complement pathway by sea cucumber fractions |
| 11/23/1999 | US5989577 Nontoxic vernix compositions and method of producing |
| 11/23/1999 | US5989563 Viral agent associated with mystery swine disease |
| 11/23/1999 | US5989562 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 11/23/1999 | US5989545 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 11/23/1999 | US5989537 Methods for stimulating granulocyte/macrophage lineage using thrombopoietin |
| 11/23/1999 | CA2103680C Improved blood substitute |
| 11/18/1999 | WO1999058678A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 11/18/1999 | WO1999058646A1 Genetically-modified fibroblasts and the use thereof |
| 11/18/1999 | WO1999058645A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 11/18/1999 | WO1999058564A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 11/18/1999 | WO1999058552A2 Peptides that ellicit t, cellular immunity |
| 11/18/1999 | WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
| 11/18/1999 | WO1999058137A1 Bio-pharmaceutical preparation containing a live culture of bacillus and method for treating viral and bacterial infections as well as immuno-deficiency conditions |
| 11/18/1999 | WO1999058136A1 Use of shark liver oil for local treatment of skin diseases of domestic animals |
| 11/18/1999 | WO1999058133A2 Anti-diarrheal and method for using the same |
| 11/18/1999 | WO1999058125A1 Metabolites of ecteinascidin 743 |
| 11/18/1999 | WO1999058095A2 Pharmaceutical and/or cosmetic compositions containing sea water |
| 11/18/1999 | WO1999058042A2 Specially devised neuronal implants for reconstruction of damaged central nervous system |
| 11/18/1999 | WO1999050393A3 Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and damage |
| 11/18/1999 | WO1999050285A3 Production methods and uses of a retrovirus |
| 11/18/1999 | WO1999047642A9 Development of normal offspring from oocytes injected with freeze-dried spermatozoa |
| 11/18/1999 | WO1999047163A3 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 11/18/1999 | WO1999046281A9 Novel polypeptides and nucleic acids encoding the same |
| 11/18/1999 | WO1999041416A3 Compositions comprising viruses and methods for concentrating virus preparations |
| 11/18/1999 | WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS |
| 11/18/1999 | WO1999027098A3 A-33 related antigens and their pharmacological uses |
| 11/18/1999 | CA2332616A1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and their uses |